Condition

Hematological Malignancy (Leukemia- Lymphoma) clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• GT719 universal cell injection for adults with relapsed or refractory CD19-positive B-cell cancers

  This trial will test whether GT719, a universal CD19-targeting cell injection, is safe and can induce remissions in adults with relapsed or refractory CD19-positive B-cell lymphoma or B-cell acute lymphoblastic leukemia.

  Recruiting Early Phase 1 Grit Biotechnology · Ganzhou, Jiangxi · NCT07131254

• Treatment for recurrent CD19 positive adult B-cell cancers

  This study is testing a new injection to see if it can help adults with certain types of B-cell cancers that have come back or didn't respond to other treatments.

  Recruiting Phase 1/2 Grit Biotechnology · Tianjin, Tianjin Municipality · NCT06948981

Quick answers

How many Hematological Malignancy (Leukemia- Lymphoma) clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →